COLGATE PALMOLIVE CO
CL · CIK 0000021665 · Perfumes, Cosmetics & Other Toilet Preparations
About COLGATE PALMOLIVE CO
Business Overview
To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet.
Business information sourced from SEC annual filing filed Feb 23, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.
Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.
Company Details
- Registered name
- COLGATE PALMOLIVE CO
- Ticker symbol
- CL
- CIK
- 0000021665
- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC SIC code
- 2844
- Fiscal year end (MMDD)
- 1231
- Last SEC synchronization
- Nov 8, 2026 15:19 UTC
Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Official website, business descriptions and executive details require separate verification.
Financial highlights
Latest qualifying annual SEC observations · USDHistorical financial performance
USD billions · Annual SEC observations · Choose a metric
Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.
Annual financial history
USD · Exact fiscal period ends| Period ended | Revenue | Net income | Operating income | Assets | Liabilities | Cash | Operating cash flow | Net margin |
|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | $20.38B | $2.13B | $3.31B | $16.33B | $15.96B | $1.29B | $4.20B | 10.5% |
| Dec. 31, 2024 | $20.10B | $2.89B | $4.27B | $16.05B | $15.50B | $1.10B | $4.11B | 14.4% |
| Dec. 31, 2023 | $19.46B | $2.30B | $3.98B | $16.39B | $15.44B | $966.00M | $3.74B | 11.8% |
| Dec. 31, 2022 | $17.97B | $1.78B | $2.89B | $15.73B | $14.92B | $775.00M | $2.56B | 9.9% |
| Dec. 31, 2021 | $17.42B | $2.17B | $3.33B | $15.04B | $14.07B | $832.00M | $3.32B | 12.4% |
| Dec. 31, 2020 | $16.47B | $2.70B | $3.88B | $15.92B | $14.82B | $888.00M | $3.72B | 16.4% |
| Dec. 31, 2019 | $15.69B | $2.37B | $3.55B | $15.03B | $14.48B | $883.00M | $3.13B | 15.1% |
| Dec. 31, 2018 | $15.54B | $2.40B | $3.69B | $12.16B | $11.96B | $726.00M | $3.06B | 15.4% |
A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.
Latest SEC filings
Browse filings →| Form | Filed | Report period | Official source |
|---|---|---|---|
| 10-Q | Oct. 30, 2026 | Sept. 30, 2026 | View SEC filing ↗ |
| 10-Q | July 31, 2026 | June 30, 2026 | View SEC filing ↗ |
| 10-Q | May 1, 2026 | March 31, 2026 | View SEC filing ↗ |
| 10-Q | Oct. 31, 2025 | Sept. 30, 2025 | View SEC filing ↗ |
| 10-Q | Aug. 1, 2025 | June 30, 2025 | View SEC filing ↗ |
| 10-Q | April 25, 2025 | March 31, 2025 | View SEC filing ↗ |
| 10-Q | Oct. 25, 2024 | Sept. 30, 2024 | View SEC filing ↗ |
| 10-Q | July 26, 2024 | June 30, 2024 | View SEC filing ↗ |
| 10-Q | April 26, 2024 | March 31, 2024 | View SEC filing ↗ |
| 10-Q | Oct. 27, 2023 | Sept. 30, 2023 | View SEC filing ↗ |
| 10-Q | July 28, 2023 | June 30, 2023 | View SEC filing ↗ |
| 10-Q | April 28, 2023 | March 31, 2023 | View SEC filing ↗ |
| 10-Q | Oct. 28, 2022 | Sept. 30, 2022 | View SEC filing ↗ |
| 10-Q | July 29, 2022 | June 30, 2022 | View SEC filing ↗ |
| 10-Q | April 29, 2022 | March 31, 2022 | View SEC filing ↗ |
| 10-Q | Oct. 29, 2021 | Sept. 30, 2021 | View SEC filing ↗ |
| 10-Q | July 30, 2021 | June 30, 2021 | View SEC filing ↗ |
| 10-Q | April 30, 2021 | March 31, 2021 | View SEC filing ↗ |
| 10-Q | Oct. 30, 2020 | Sept. 30, 2020 | View SEC filing ↗ |
| 10-Q | July 31, 2020 | June 30, 2020 | View SEC filing ↗ |
Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.